— Know what they know.
Not Investment Advice

PRAX NASDAQ

Praxis Precision Medicines, Inc.
1W: +1.5% 1M: +3.9% 3M: +4.6% YTD: +22.4% 1Y: +783.0% 3Y: +2125.8% 5Y: +7.7%
$343.56
-7.00 (-2.00%)
 
Weekly Expected Move ±5.0%
$308 $326 $343 $360 $377
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 54 · $7.3B mcap · 23M float · 1.74% daily turnover · Short 70% of daily vol

Cash Flow Trends

Operating Cash Flow
-$249M -89.0% ▼
Capital Expenditures
$56K +0.0% ▲
Free Cash Flow
-$249M -89.1% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$142M +5.9% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$167M-$214M-$123M-$183M-$303M
Depreciation & Amort.$182K$419K$432K$358K-$3M
Stock-Based Comp.$23M$29M$25M$41M$34M
Change in Working Capital$16M-$2M-$13M$11M$23M
Other Non-Cash Items$1M$2M-$121K-$2M$1M
Operating Cash Flow-$125M-$185M-$111M-$132M-$249M
— Investing Activities —
Capital Expenditures-$1M-$444K-$50K$0-$56K
Acquisitions (Net)$139M-$97M$0$0$0
Investment Purchases-$164M-$83M$0-$372M-$624M
Investment Sales$25M$180M$39M$123M$313M
Other Investing-$139M$97M$0$0$0
Investing Cash Flow-$141M$97M$39M-$248M-$311M
— Financing Activities —
Net Debt Issuance-$763K$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$3M$904K$279K$2M-$2M
Financing Cash Flow$108M$10M$92M$514M$702M
Net Change in Cash-$157M-$78M$20M$134M$142M
Cash End of Period$140M$62M$82M$216M$358M
Free Cash Flow-$126M-$185M-$111M-$132M-$249M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms